Director Medical Development, MRD Breast Portfolio

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

The Director Medical Development, MRD Breast Portfolio, will be responsible for clinical and translational leadership in the development and execution of the company’s precision oncology strategies; including, but not limited to, the design and implementation of next-generation sequencing (NGS) based assays, focused on the development, validation, and regulatory approval of diagnostic tests designed to help determine the most appropriate therapies for breast cancer patients, monitor therapy effectiveness, and detect the presence of residual disease.

In partnership with the Product and Medical Strategy teams, this role will provide medical leadership during the design, implementation, and reporting of studies that support pipeline products and/or line extensions to on-market products. This position will develop external relationships with oncology leaders at academic institutions, cooperative groups, and research organizations, identifying investigators and sites to inform medical strategies and participate in clinical trials.

The Director Medical Development, MRD Breast Portfolio, will initiate and lead external ad boards involving medical leaders in pharma, key opinion leaders, and other third parties. This position will be responsible for the review, interpretation, and leadership in translation of key study results into evidence-based claims and will help design and implement the medical support for all new or extended precision oncology tests and services with applications to breast cancer patients.

The Director Medical Development, MRD Breast Portfolio will be both a leader of and participant on internal cross-functional program teams and working groups including, but not limited to, members of the business development, research and development, pathology and clinical lab operations, biostatistics, clinical affairs, medical affairs, regulatory, market access, and commercial teams. This position will also provide medical leadership across Precision Oncology as a member of the medical organization.

This position can be based in Redwood City, CA, San Diego, CA, or be field based.

• Develop the overall vision and strategy for one or more specific Precision Oncology (PO) products, including, but not limited to, the Oncotype DX recurrence score;
  Onco Ex Tra  and therapy selection portfolio; the molecular residual disease (MRD) liquid biopsy portfolio, and digital pathology algorithms, as apply to the clinical care of breast cancer patients, in partnership with internal and cross-functional stakeholders including commercial, product, compliance, market access, and regulatory.
• Identify opportunities to expand indications for existing PO products and new products within the biotech/pharma space.
• Collaborate with cross-functional team members from the research and development, product, and commercial organizations to participate in and provide medical expertise to the formulation of commercialization strategy and the creation of product profiles for new products and services.
• Participate as the medical monitor on study teams and lead the development and implementation of clinical protocols required to support product development, validation, and commercialization; including, but not limited to, the adoption and development of novel approaches for the demonstration of clinical validation and utility.
• Engage with medical leaders within medical and surgical and radiation oncology to gain a greater understanding of key clinical questions in patient management, requisite a new generation of clinical tool needs, and facilitate their understanding of the scientific validity and clinical utility of Exact PO products.
• Accountable for scientific presentations and publications generated as a result of PO product development collaborations.
• Provide oncology expertise and clinical insight for cross-functional teams throughout the lifecycle of practice-changing multiomic tests and services.
• Engage with colleagues in the medical organization to drive continuous improvement of team leadership practices…